Definitive Healthcare CORP (DH) 13F Holdings Overview (Q2 2026)

DH ranks #4580 out of 37503 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

DH is a disclosed holding of David Shaw (D. E. Shaw & Co.), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

101 institutions disclose a position in DH, but none treat it as a major bet — even Advent International, L.p., its most concentrated holder, allocates just 0.3% of its own portfolio to it.

Acadian Asset Management LLC has added to its DH position for two straight quarters, increasing it by $337.0K to reach $368.0K today.

Advent International, L.p. has trimmed its DH position for two straight quarters, cutting it by $128.6M while still holding $51.9M.

DH is up 15.3% today, and institutions have been net buyers of $1.6M this quarter — today's price move and the underlying institutional flow are pointing the same direction.

DH reported a net loss of $168.2M over the trailing twelve months.

• Not yet profitable — net loss of $168.2M over the trailing twelve months
• Revenue declined 5.0% year over year
• Net income improved year over year, from -$304.8M to -$168.2M
• Generated $53.8M in positive operating cash flow
• Current ratio of 1.64x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.94x equity — within a conventional range